(Q43125212)

English

Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor

scientific article published in June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Utility of the carboxylesterase inhibitor bis-para-nitrophenylphosphate (BNPP) in the plasma unbound fraction determination for a hydrolytically unstable amide derivative and agonist of the TGR5 receptor (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

object named as

H Eng

1

0 references

author name string

M Niosi

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

T S McDonald

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

A Wolford

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Y Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

S T M Simila

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

J N Bauman

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

J Warmus

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

A S Kalgutkar

9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

369-380

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

GLP-1 based therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Chromatographic study on the specificity of bis-p-nitrophenylphosphate in vivo. Identification of labelled proteins of rat liver after intravenous injection of bis-p-nitro[14C]phenylphosphate as carboxylesterases and amidases

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Structure-based optimization of novel azepane derivatives as PKB inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Development and application of high throughput plasma stability assay for drug discovery

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Influence of the carboxylesterase inhibitor bis-p-nitrophenylphosphate on the rates of hydrolysis of various alpha-esters of 1-(N-methyl-N-nitrosamino)-methanol in vitro and in vivo and on the acute toxicity and carcinogenicity of 1-(N-methyl-N-nitr

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

New water-soluble prodrugs of HIV protease inhibitors based on O-->N intramolecular acyl migration

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

A method for the estimation of esterase synthesis and degradation and its application to evaluate the influence of insulin and glucagon

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

The developmental multiplicity and isoenzyme status of cavian esterases

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Transport and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in Caco-2 cells

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Is 1-aminobenzotriazole an appropriate in vitro tool as a nonspecific cytochrome P450 inactivator?

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice.

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

High-throughput determination of the free fraction of drugs strongly bound to plasma proteins

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Targeting bile-acid signalling for metabolic diseases

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

In vitro stability and metabolism of salvinorin A in rat plasma

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Esterases in histochemistry and ultrahistochemistry

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Integrated strategies for assessment of metabolite exposure in humans during drug development: analytical challenges and clinical development considerations.

1 reference

https://api.crossref.org/works/10.3109%2F00498251003706598

21 January 2018

Identifiers

10.3109/00498251003706598

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43125212&oldid=1981344088"